ARTICLE | Clinical News
Imvanex regulatory update
March 5, 2012 8:00 AM UTC
Bavarian submitted an MAA to EMA for its Imvanex smallpox vaccine. The company expects a decision on the vaccine next year. The third-generation modified vaccinia Ankara (MVA) virus vaccine is under review in Canada, where the company expects a decision this year. ...